Biological Innovations

IDRIA B

Injectable PRF​ (iPRF), Standardized

Additive-free, injectable platelet-rich fibrin prepared from whole blood in a short, single-spin process. Designed for routine clinical workflows and fine-gauge injection.

IDRIA B is a no-anticoagulant, no-gel tube system for preparing injectable PRF (iPRF) at the point of care. A short, low-rcf centrifugation concentrates platelets and leukocytes in plasma. After injection, the fibrin network polymerizes in situ, forming a soft matrix. Use is at clinician discretion and subject to local regulation.

Idria B retains the fluid nature of platelet-rich plasma while predominantly having mononuclear cells and a concentrated reservoir of growth factors. Compared to baseline whole blood, it delivers a significantly higher platelet concentration , which directly enhances the release of bioactive proteins such as PDGF, VEGF, TGF-β, and EGF. These preparations contain platelet-derived factors associated with angiogenesis, collagen remodeling, and follicular stimulation; clinical application remains at the discretion of the physician.

With minimal instrumentation and materials required, Idria B offers a cost-effective solution for volumetric and Its optimized single 5-minute spin process yields a highly concentrated mix of regenerative cells and signaling proteins.

why

idria b

No anticoagulants, activators, or gels

Short single-spin protocol designed for everyday practice

Suitable for fine-gauge delivery before clot formation

Closed tube and defined time/force/volume parameters

How

it works

30 mL whole blood directly into IDRIA B tubes (no anticoagulant).

Using the specified low-rcf, short-time protocol (see IFU).

Promptly and inject within the working time per IFU to allow in-situ fibrin polymerization.

technical

snapshot*

*Operational parameters and yields vary by technique, equipment, and donor factors. Refer to the product IFU.

30 mL whole blood (per IFU volume)

Single, short spin at low rcf (×g)

Injectable PRF (platelets + leukocytes in plasma) with a short working time prior to gelation

Design

Features

Versatility

For clinician-directed protocols

(Soft fibrin matrix)

Where permitted by local practice and regulation

Areas of

Clinical use

At clinician discretion, iPRF is used across:

Aesthetic Dermatology & Hair

Dental/Oral Surgery

Plastic & Reconstructive

Orthopedics & Sports Medicine

Wound Care

Permitted uses and availability vary by country; follow local regulations and guidelines.

Quality &

Documentation

  • Parameters defined: time/rcf/volumes and working-time guidance
  • Documentation: IFU/SOP, QC & batch templates, traceability
  • Labeling: multilingual inserts/labels where applicable

Important information
The product is CE marked, certifying compliance with the essential requirements of European legislation governing medical devices. For professional use only. Product availability, regulatory status, and indications vary by market. Consult the IFU and local regulations before use.

Discover more

If you want to learn more about Idria S+, please get in touch.